Amerise Biosciences Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported revenue was INR 0.001 million compared to INR 0.001 million a year ago. Net loss was INR 0.606 million compared to INR 0.514 million a year ago. Basic loss per share from continuing operations was INR 0.01 compared to INR 0.01 a year ago. Diluted loss per share from continuing operations was INR 0.01 compared to INR 0.01 a year ago.
For the nine months, revenue was INR 0.001 million compared to INR 0.087 million a year ago. Net loss was INR 1.66 million compared to INR 0.986 million a year ago. Basic loss per share from continuing operations was INR 0.03 compared to INR 0.01 a year ago. Diluted loss per share from continuing operations was INR 0.03 compared to INR 0.01 a year ago.